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Tubular catabolism of albumin is associated with the release of an
inflammatory lipid. Proteinuria and tubulointerstitial inflammation (Til)
correlate with progression to renal failure in human glomerulonephritis.
Various forms of experimental nephrotic syndrome are associated with
TI!. To study the genesis of TI!, we utilized the model of albumin
overload. Rats received intraperitoneal bovine serum albumin (BSA)
for 1 to 14 days, developing heavy proteinuria. A predominantly
macrophage interstitial infiltrate was present at days 3, 7 and 14. The
urine of the rats contained a factor chemotactic for macrophages which
partitioned into the organic phase with ethyl acetate extraction. TLC
and HPLC characteristics were those of a novel, non-polar lipid.
Supernatant from the culture of proximal tubule (PT) segments after in
vivo or in vitro exposure to high concentrations of lipid-replete BSA
showed chemotactic activity with similar chromatographic characteris-
tics. PT cultured with delipidated BSA produced little activity. Thus,
the generation of this inflammatory factor occurs as a consequence of
tubular metabolism of albumin-borne fatty acids and may contribute to
the development of proteinuria-associated TI!.
The presence of nephrotic-range proteinuna in human gb-
merulonephntis (GN) correlates with progression to end-stage
renal disease [1, 2]. This correlation is present regardless of the
histologic diagnosis. Additionally, associations between tubu-
lointerstitial disease and decreased renal function have been
described for a wide range of glomerulopathies [3—6]. Indeed,
decline in glomerular filtration rate (GFR) shows a higher
correlation with tubulointerstitial changes than with glomerular
appearance at the time of renal biopsy [3]. In the experimental
setting, links between nephrotic-range proteinuria and tubulo-
interstitial inflammation have been shown in puromycin amino-
nucleoside (PAN) nephrosis [7—9] and in protein-overload pro-
teinuria [10].
The mechanism by which proteinuria per se is associated
with interstitial inflammation and fibrosis is unknown. We
sought to determine whether tubular uptake of albumin would
result in the release of a chemotactic factor that could initiate
the infiltration of the interstitium by leukocytes in the context of
nephrotic-range proteinuria. We employed the albumin-over-
load model of proteinuria because it offers a relatively pure
model of the consequences of proteinuria in the absence of
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activation of humoral immunity or exposure to tubular toxins
[10]. The many previous studies of this model have focused on
glomerular changes during proteinuna [11, 12]; however, Eddy
has described interstitial inflammation during protein overload
[10].
Our observations indicate that the presence of albumin in the
tubular lumen is causally linked to the interstitial infiltration of
monocytes. The mechanism appears to be the production of a
novel, epithelium-derived chemotactic lipid generated by the
tubular metabolism of albumin-associated fatty acids.
Methods
Animals
Lewis rats were obtained from Harlan Sprague-Dawley (In-
dianapolis, Indiana, USA). Rats were 6 to 12-weeks-old and
weighed 150 to 250 grams at the time of the study. They were
maintained on standard rat chow (22% protein, Ralston Purina,
St. Louis, Missouri, USA) and given free access to tap water.
Experimental design
Rats received once daily intraperitoneal injections of 2 grams
of bovine serum albumin (BSA) (fraction V, endotoxin-free,
Sigma Chemical Corporation, St. Louis, Missouri, USA) while
anesthetized with ether. BSA injections were given once daily
for periods ranging from 1 to 14 days. Rats were individually
housed in metabolic cages with free access to tap water on days
1, 2, 3, 7, and 14, and urine was collected. The urine sediment
was removed via centrifugation, and the urine was passed
through a 0.2 micron filter prior to processing. Groups of
animals were sacrificed after 1, 3, 7, or 14 days of albumin
overload after anesthetization with inhaled ether and intraper-
itoneal pentobarbital. Serum was obtained by aortic exsangui-
nation. Kidneys were removed and decapsulated, and pro-
cessed for light microscopy, cortical leukocyte labeling, frozen
sections, or proximal tubule segment culture as detailed below.
Normal litter mates of the experimental rats served as controls.
(Throughout this paper, a procedure which is designated "Day
3" was done after 3 daily injections, "Day 7" after 7 daily
injections, and etc. For urine collections, the collection began
after the designated injection and continued to the next day.
Animals were sacrificed after the completion of the urine
collection on the day following the final injection.)
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Serum biochemistry
Serum BUN and creatinine were measured using an I.L.
Multistat (Fisher Scientific, Lexington, Massachusetts, USA).
Serum rat albumin and BSA were quantitated utilizing commer-
cially available radial immunodiffusion kits (The Binding Site,
Birmingham, UK).
Urine biochemistry
Total urine protein was measured using the modified Brad-
ford assay (Bio-Rad Laboratories, Richmond, California,
USA). Urine rat albumin and bovine albumin were quantitated
by radial immunodiffusion as noted above for serum.
Light microscopy
Sectioned renal tissue was fixed in 10% formalin and pro-
cessed for routine light microscopy. Sections were stained with
hematoxylin and eosin. The sections were qualitatively as-
sessed for evidence of tubular damage (loss of brush border,
detachment from basement membrane), presence of protein
casts, and presence of an interstitial infiltrate. The degree of
interstitial inflammation was quantitated by counting the num-
ber of cortical extratubular nuclei (excluding glomeruli) per 15
50x fields for each animal.
Leukocyte labeling studies
Chemicals. The following antisera were employed for subset
labeling:
(a.) Mouse monoclonal anti-rat leukocyte common antigen
(clone OXl), whose specificity has been detailed [13].
(b.) Polyvalent rabbit anti-rat macrophage antiserum absorbed
against other leukocytes (Accurate Chemicals, New York,
USA).
(c.) Mouse monoclonal anti-rat T lymphocyte, suppressor sub-
set (clone 0X8, Accurate Chemicals).
(d.) Mouse monoclonal anti-rat B lymphocyte (clone 0X33,
Accurate Chemicals).
(e.) Mouse monoclonal anti-rat T lymphocyte (clone 0X52,
Accurate Chemicals).
(f.) Fluorescein-conjugated goat anti-rabbit immunoglobulin
(Vector Laboratories, Burlingham, California, USA), and
fluorescein-conjugated rat anti-mouse immunoglobulin
(Vector Laboratories), as second antibodies.
Cortical tissue was labeled for cells expressing leukocyte
antigens using a previously published protocol [14]. Briefly,
portions of renal cortex were minced through sieves with pores
of 500 and then 250 microns. After washing, the tissue was
placed in a digestion medium containing Hank's Balanced Salt
Solution with 1% Hepes buffer, type II collagenase (500 tgIml),
DNAase (0.01 mg/mI) and soybean trypsin inhibitor (1 mg/mI),
and rotated at room temperature for 20 minutes. The digested
material was washed and placed in 1 msi EDTA for 10 minutes.
The material was again washed, resuspended and allowed to
settle for one minute. The supernatant, consisting of epithelial
cells and leukocytes as single cells or in clumps, and intact
glomeruli, was collected, and separate aliquots were labeled
with one of the primary (50 g/ml) and appropriate secondary
antibodies (50 .tgIml) as listed above. After washing, the cells
were fixed in 2% paraformaldehyde in PBS. The labeled cells
were counted with a Nikon Optiphot 2 fluorescent microscope;
labeled cells in glomeruli were excluded from the count. Results
are expressed as the number of positive cells per gram of
cortical tissue (wet wt).
ED-i labeling of renal tissue
Pieces of kidney were snap frozen in ethanol cooled in dry
ice. Ten micrometer sections were subsequently cut from the
frozen tissue, mounted on slides and stored at —20°C. Sections
were labeled with mouse anti-rat ED-i (Serotec, Oxford, UK),
also using a previously published protocol [15]. Briefly, sections
were fixed in chilled acetone for 10 minutes. Endogenous
peroxidase activity was inhibited by immersion for five minutes
in 0.07% H202 in PBS. Endogenous biotin activity was inhib-
ited by sequential 30 minute exposures to Avidin D and biotin
blocking solutions (Vector Laboratories). The sections were
placed in dilute horse serum as a blocking solution, followed by
ED-l antibody (diluted 1:10 in PBS containing 10% horse
serum) for 30 minutes. After washing, biotinylated horse anti-
mouse IgG (Vector Laboratories) was added for 15 minutes.
After washing, the slides were sequentially exposed to strepta-
vidin-peroxidase, and amino ethyl carbazide and hydrogen
peroxide, as supplied by Zymed Laboratories (San Francisco,
California, USA). The sections were counterstained with he-
matoxylin and mounted under coverslips. Sections were eval-
uated qualitatively regarding the localization of the interstitial
infiltrate. Cortical macrophages were also enumerated by enu-
merating the extraglomerular ED-i positive cortical cells per 10
40x fields for each animal.
Labeling of kidney sections for complement and IgG
Kidneys from rats receiving albumin for three days and for
seven days were perfused with PBS in situ, harvested, and snap
frozen. Ten micrometer frozen sections were prepared and
placed in acetone at 10°C for 30 minutes. Labeling for comple-
ment was carried out by placing the sections in 3% bovine
serum albumin (Sigma) in PBS for 15 minutes, washing, and
then exposing to FITC-conjugated rabbit anti-rat C3 (Cappel
Laboratories, West Chester, Pennsylvania, USA), 10 p.g/ml for
20 minutes at room temperature. The sections were then
washed four times and examined via fluorescent microscopy
(Nikon Optiphot 2). They were scored I + to 4+, 1 + being
discernible but not confluent fluorescent deposits, and 4+ being
dense, confluent deposits. The concentration of anti-rat C3 was
chosen by comparison of labeling with varying concentrations
of antibody kidney sections from rats receiving incremental
doses of rabbit nephrotoxic serum (NTS) inducing 24-hour
albumin excretion ranging from 10 mg to 180 mg/day. Ten sg/ml
of anti-rat C3 yielded a 1 + reaction in rats that developed the
lowest protein excretion of 10 mg/day. Labeling for rat IgG was
carried out identically except for the application of FITC-rat-
anti-mouse IgG (Vector Laboratories) at 10 /.Lg/ml. This con-
centration was also chosen by comparison to the positive
standards noted above.
Proximal tubule culture
Proximal tubule segments were isolated under sterile condi-
tions by a modification of a previously described method [16].
For separate experiments, proximal tubule segments were
isolated either from rats that had received 1 to 14 days of
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intraperitoneal BSA, or from normal rats. Renal cortex was
dissected, sliced on a Stadie-Riggs microtome, and digested for
45 minutes at 37°C in a solution of 30 mg collagenase D
(Worthington) and 100 mg BSA (Sigma) in 15 ml Krebs buffer
with 5 ifiM glucose. The tubular suspension was filtered through
a tea strainer, washed, and resuspended in 50% Percoll (Sigma).
The Percoll solution was centrifuged at 15,000 x g in a Sorvall
RC-SB centrifuge at 4°C for 30 minutes. The bottom layer of the
resultant preparation contained proximal tubule segments and
was collected, washed and placed in overnight culture in K-i
medium at a protein concentration of 0.3 mg/mi. Medium K-I
consists of a 50:50 mixture of Dulbecco's modified Eagle's and
Hamm's F12 media; 15 msi Hepes; 13.4 m sodium bicarbon-
ate; 5 g/ml insulin, 5 g/ml transferrin, 5 ng!ml selenous acid
(ITS Premix, Collaborative Research, Bedford, Massachusetts,
USA); 0.05 LM hydrocortisone (Sigma); 10 ng/ml epidermal
growth factor (Sigma); and 50 LM PGEI (Sigma). In some
instances, when normal rat tubules were used, the media
contained 5 mg/mI of either lipid-replete or lipid-depleted BSA
(Sigma). Proximal tubule segments were cultured for 24 hours.
Aliquots of 10 ml of supernatant from all experimental condi-
tions were subsequently collected and processed as detailed
below.
Purity of the proximal tubule preparation was assessed by
demonstrating alkaline phosphatase activity following fixation
of the isolated tubules to a slide utilizing a Shandon Cytospin 2.
The fixed cells were incubated with naphthol As-Mx phosphate
and fast blue RR salt (Sigma, Kit #85). Blue staining of alkaline
phosphatase positive cells resulted. Some tubular segments
were also exposed to rabbit anti-rat macrophage antiserum and
subsequently to fluorescein-conjugated goat anti-rabbit immu-
noglobulin to check for contaminating macrophages.
To remove any contaminating macrophages, some cultures
were incubated with rabbit anti-macrophage antiserum and
rabbit serum (as a complement source) for one hour at the start
of the culture period. Control cultures were incubated with
heat-inactivated fetal calf serum. After one hour, the prepara-
tions were washed and placed into culture as previously de-
scribed above.
BSA ELISA
Intracellular BSA from the proximal tubule segment cultures
was measured using standard ELISA techniques. Proximal
tubules were obtained as previously detailed and cultured in
either K-i medium or K-i with 5 mg/ml of lipid-replete or
lipid-depleted BSA for 90 minutes. This time interval has
previously been shown to reflect the kinetics of albumin uptake
by tubular epithelial cells, but precedes catabolism of albumin
to single amino acids [17]. Some cultures were incubated in the
cold (10 to 15°C) to measure non-specific uptake. The tubules
were scraped from the culture flask and the tubular suspensions
were washed extensively with cold HBSS. Following washing,
the tubular pellet was resuspended in HBSS and the cells were
lysed via sonication.
Aliquots of the resultant suspension were bound to polyvinyl
ELISA plates (Costar, Cambridge, Massachusetts, USA), as
were known concentrations of BSA in PBS, pH 9.5, for 90
minutes at 37°C. The plates were subsequently blocked with 2%
goat serum in 0.05% PBS/Tween at room temperature (RT) for
30 minutes. One hundred microliters of rabbit anti-BSA (Sigma)
diluted 1/1250 in PBS were added to each well for 90 minutes
(RT). The primary antibody was followed by 50 .d of biotiny-
lated anti-rabbit IgG (Vector Laboratories) for 30 minutes (RT)
and then 100 p1/well of the Vectastain glucose oxidase reagent
(Vector Laboratories) for 15 minutes (RT). Extensive washing
with PBS was done after each of the above steps. The plates
were developed with 100 p1/well of a substrate solution consist-
ing of 50 m citrate/phosphate buffer, pH 5.3 with 7.5 mg/ml
glucose, 0.5 mg/mi o-phenyienediamine dihydrochloride and 0.1
p1/ml horseradish peroxidase. The plates were allowed to
develop for 10 to 15 minutes in the dark and the reaction was
then stopped by the addition of 50 p1/well of 4 M H2S04 to the
substrate. Absorbance of each well was read at 450 nm, a
standard curve was plotted and the concentration of BSA in
each sample was calculated by comparison to the standard
curve.
Ethyl acetate extraction
Initial experiments with chloroform/methanol extraction of
lipids resulted in fairly rapid decay of chemotactic activity when
the extract was stored. Material extracted with ethyl acetate
was more stable, and this extraction was therefore used for the
experiments described in the paper. Urine or supernatant lipids
were extracted by centrifugation with 4 to 5 volumes of ethyl
acetate. The organic (upper) layer was collected and the extrac-
tion was repeated twice. The pooled organic extract was dried
under nitrogen, then stored prior to further testing.
Timed urine collections were done in all experiments involv-
ing urine testing. Extracts of urine collected over equivalent
time periods were compared in the experiments describing
urine chemotactic activity. For the experiments involving cell
culture, 10 ml of supernatant were extracted for each experi-
ment.
Chemotaxis assay
Chemotactic activity of urine or of supernatant extracts was
assessed by a modification of the method of Falk, Goodwin and
Leonard [18]. Microchemotaxis chambers were purchased from
Neuroprobe (Cabin John, Maryland, USA), and filters from
Poretics Corporation (Livermore, California, USA). The re-
sponder cells were RAW 264.7 (ATCC, Rockville, Maryland,
USA), a mouse monocyte cell line which has been shown to
replicate normal monocyte chemotactic responsiveness to both
protein and lipid chemoattractants [19].
The dried extract to be tested was suspended in RPMI with
0.25% delipidated albumin, 1% glutamine, Hepes and penicillin!
streptomycin, and 30 p1 of the suspension were placed in a
bottom well of the plate. 0.5% zymosan activated serum was
used as a positive control, and media alone as a negative
control; 50,000 RAW cells in the same media were placed in the
upper chamber, separated from the sample by the filter. Mter
an incubation of three hours, the filters were fixed and stained
(Diff-Quik Process, Baxter Corporation, McGraw Park, Illinois,
USA), and mounted on slides for microscopic examination.
Each sample was tested in triplicate; 5 50x fields were counted
per well.
Because the chemotaxis assay is a bioassay subject to many
factors which may alter activity, the positivity of the assay,
measured by the number of cells migrating toward zymosan
activated serum, varied from day to day. Therefore, two
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different methods were used to express results. When all
samples in an experiment were run in the same assay, or when
the positive control response for various assays differed by less
than 10%, the results are expressed as the difference between
total cells migrating toward a chemoattractant and cells migrat-
ing toward media alone. When several assays in which the
positive control response was variable were used, results are
expressed as a percentage of the positive control response.
Extraction chromatography
Extracts were passed over silica columns (JT Baker Chemical
Company, Phillipsburg, New Jersey, USA) in 70% ethyl ace-
tate/30% isopropanol. The pooled extract was collected after
column passage, and dried under nitrogen for further testing.
Thin layer chromatography
Following column extraction, the lipid extract was spotted on
a thin layer chromatography (TLC) plate (Sigma) and chromato-
graphed in a solvent system of chloroform/methanol/acetic acid
(65:25:5). Each lane was divided into ten equivalent bands and
scraped. Lipids from each fraction were eluted with several
volumes of chloroform/methanol (2:1), dried under nitrogen and
stored until chemotaxis testing. Some plates were sprayed with
Phospray (Supelco, Beilfonte, Pennsylvania, USA), a molyb-
date-containing phospholipid detector.
High-performance liquid chromatography
Following column extraction, the lipid extract was suspended
in acetonitrile/H20 (25:75) and subjected to reverse-phase,
high-performance liquid chromatography (HPLC) using a Per-
kin-Elmer LC1-lOO (Stamford, Connecticut, USA). Chromatog-
raphy was carried out on a 15 cm column (Supelco). The
starting solvent system was acetonitrile/H20 (75:25) for five
minutes, followed by a linear gradient over 15 minutes to 100%
acetonitrile, with a final five minutes at 100% acetonitrile. One
minute fractions were collected at a flow rate of 1.2 mI/mm,
dried under nitrogen and stored for further testing.
Specificity of chemoattractant
To test the specificity of the chemotactic factor for mono-
cytes/macrophages, extracted urine was tested in the previ-
ously described chemotaxis system while varying the responder
cells. RAW 264.7 cells, described above, were considered
representative of chemotactically active monocytes. Rat peri-
toneal macrophages were obtained via peritoneal lavage two
days following intra-peritoneal injection of 5 cc of heat-inacti-
vated fetal calf serum. Rat polymorphonuclear cells were also
collected by peritoneal lavage two hours after an intraperitoneal
injection of shellfish glycogen. Chemotactic response of each of
these cell types was tested against identical, HPLC purified
urine extracts from three rats at day 3 of protein overload.
Modflcation of chemoattractant
Following column extraction, the lipid extract was subjected
to alkaline and acid hydrolysis. The dried extract was resus-
pended in 1 ml of 0.5 M methanolic KOH, or 1 ml of 0.5 M
methanolic HC1 for 30 minutes at room temperature. The
reactions were stopped by the addition of an equal volume of
0.5 M methanolic HCI or 0.5 M methanolic KOH. The material
was dried under nitrogen and stored for further testing.
The lipid extract was also tested for heat stability. Mter
drying to a film, following column extraction, the lipid extract
was heated to 100°C for one hour, then stored for further
testing.
Storage
All extracts were stored in ethyl acetate under argon in
siliconized glassware at —20°C until further purification and/or
chemotaxis testing was performed. No samples were stored for
more than two months prior to use.
Statistics
All results are expressed as mean standard error of the
mean. Results of the biochemical studies were compared using
an unpaired Student's t-test. The studies of the interstitial cell
population were analyzed using the Mann-Whitney test for
non-parametric comparison.
Results
Urinary protein
All of the protein-overloaded rats (N = 45) became heavily
proteinuric (Fig. 1) and remained proteinuric throughout the
study. Peak proteinuria occurred at 3 days, reaching a mean
level of 739 161 mg/24 hr. Rat albumin appeared in the urine
as early as day 2 and was uniformly present by day 3, with a
mean value of 20 8.3 mg/24 hr. The amount of rat albumin did
not increase significantly through the rest of the study period.
Greater than 90% of the remaining urinary protein was bovine
albumin.
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mg/24 hours, mean SE. * P 0.003 vs. day 0. N = 3 to 20 urine
samples collected at each time point.
p 
I 
I 
F a
 
I' 
IIV
/jA
,4 
/1
;//
] * 
*
 
Kees-Folts et a!: A proteinuria-associated inflammatory lipid 1701
Table 1. Serum biochemical profile
BUN Cr RSA BSA
gIdImg/d!
Control 16.3 0.14 0,3 0.03 3.54 0.26 NDC
Day 3 22.5 0.26a 0.5 0.03 2.82 0.21 4.51 021b
Day 7
Day 14
31.4 2.8a
25.4 i.4 0.4 0.030.3 0.03 2.06 O.O62.62 0.66 5.18 0.86"4.67 014b
Determination of blood urea nitrogen (BUN), creatinine (Cr), rat albumin (RSA) and bovine albumin (BSA) throughout the course of albumin
overload. N = 3 at each time point.
a 0.05 vs. control
b p 0.01 vs. control
None detected
Serum biochemistry
Serum creatinine (Sr) in protein-overloaded animals did not
differ from controls except at day 3, the time of peak proteinuria
(Table 1). Animals at day 3 showed elevations in both BUN and
Se,.. Following that time, SCr returned to baseline levels;
however, BUN remained somewhat elevated, perhaps reflect-
ing increased protein catabolism due to hyperproteinemia. BSA
was present in the serum of experimental animals at all of the
tested time periods. Although there was a concomitant decrease
in rat serum albumin, the animals were hyperalbuminemic
throughout the study.
Characterization of tubulointerstitial changes
On light microscopic examination, changes in the kidneys of
protein-overloaded rats included tubular vacuolization, proba-
bly representing protein absorption droplets, the presence of
protein casts and the presence of a moderate interstitial infil-
trate (Fig. 2A). All of these changes were seen at all of the
examined time periods except for tubular vacuolization which
had largely resolved by day 14. No necrotizing changes, such as
loss of tubular brush border, or basement membrane detach-
ment, were seen in tubules in any of the examined sections at
any time period.
Labeling of digested renal cortex with anti-leukocyte antibod-
ies quantitated the presence of the interstitial infiltrate. Figure 3
shows results for cortical cells reactive for leukocyte common
antigen. Infiltrating leukocytes were seen as early as day 3 and
remained throughout the two week time period. Specific subset
labeling was carried out for days 3, 7 and 14, as shown in Table
2. At all of the time points, macrophages were the predominant
cell type. Small numbers of T lymphocytes (0X52 positive)
were seen at days 7 and 14; the total number of T cells was
accounted for by CD8 (0X8 positive) cells. No T lymphocytes
or B lymphocytes were observed in control preparations.
Staining of kidney frozen sections with the ED-i antibody,
which recognizes a cytoplasmic macrophage antigen, also
showed the macrophage infiltration to be peritubular (Fig. 2B).
ED-i positive cells were seen surrounding proximal, but not
distal tubules in the renal cortex of experimental kidneys. As
shown in Table 3, quantification of ED-i positive cortical cells
revealed a progressive increase in the macrophage infiltrate
through the course of the study. Enumeration of peritubular
cells on tissue sections stained with hematoxylin and eosin also
showed a generalized increase in interstitial cellularity (Table
3). The majority of the increase in interstitial cellularity was
accounted for by the infiltrating macrophages.
In one experiment, frozen kidney sections from three rats at
day 3 and three rats at day 7 were stained for the presence of rat
IgG and C3. As described under Methods, rats receiving varied
doses of nephrotoxic serum sufficient to induce albuminuria
from 10 mg/day to 180 mg/day were used as positive controls.
At dilutions of specific antibody sufficient to yield clearly
positively stained glomeruli in animals with mild (10 mg/day)
proteinuria induced by NTS, neither rat IgG nor C3 were
detectable in the glomeruli of any of the nephrotic rats. These
results are consistent with those previously demonstrated in the
protein-overload model [10].
Urine chemotactic activity
Given the absence of histologic evidence of tubular toxicity,
we examined the urine of control and albuminuric rats for the
presence of a chemotactic factor that would explain the recruit-
ment of leukocytes to the interstitium. The chemotactic re-
sponse of the monocyte was investigated because it was the first
leukocyte to migrate into the renal cortex and remained the
predominant cell type in the interstitial infiltrate.
In an initial study of chemotactic activity in urine from three
control animals and six experimental animals at day 7, urine
from the proteinuric animals exhibited a significantly higher
level of chemotactic activity than that in control urine (Fig. 4).
To determine whether the active factor was a protein or lipid,
the positive urine preparation was extracted with ethyl acetate.
All of the chemotactic activity partitioned into the organic
phase of the ethyl acetate extraction; in fact, the lipid extract
showed enhanced activity, while the aqueous phase showed no
activity (Fig. 4). Further studies on the rat urine (and on cell
culture supernatants, to follow) were therefore done on the lipid
extract. In the experiments described within this paper, approx-
imately 75 rats have been subjected to protein overload. In all
cases, extracted urine from various time points ranging from 3
to 14 days of albumin overload has shown high levels of
chemotactic activity.
Passage of the extracted urine over silica columns in ethyl
acetate/isopropanol (70:30) resulted in 70 to 100% of chemotac-
tic activity remaining in the fraction which passed through the
column. In this preparation, more than 95% of phospholipids,
including platelet activating factor (PAF) and phosphatidyl
choline, were retained on the preparative silica columns. Fol-
lowing column extraction, the resuspended extract was spotted
on a TLC plate and run in the chloroform/methanol/acetic acid
system as described under Methods. Chemotactic activity mi-
grated at an R of 0.9 to 1.0 (Fig. 5a). Non-polar lipid standards
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Fig. 2. A. Hematoxylin and eosin staining of the renal cortex of a rat with albumin-overload proteinuria (day 7). Note the presence of proximal
tubular vacuolization, without evidence of necrosis. There is a diffuse increase in peritubular interstitial cellularity, characteristically most intense
close to glomeruli (x400). B. Immunohistochemical labeling of cortical cells expressing the macrophage ED-l antigen in a rat at day 14 shows that
the infiltrating cells are macrophages. The position of the positively labeled (black) cells, surrounding the tubules, is similar to that shown by the
interstitial cells in A.
including triglycerides, cholesterol esters, and diglycerides also
migrated in this region. No phospholipids were detected in this
region when the TLC plate was stained with molybdate.
The lipid material extracted from the silica columns was also
run on reverse-phase HPLC as described, and the resulting one
minute fractions were tested for chemotactic activity. In this
system, peak chemotactic activity eluted between 18 and 19
minutes (Fig. 6a). The mobility of the factor on both TLC and
HPLC indicates that it is a non-polar lipid. Silica column, TLC
and HPLC characterizations of the urine extracts were each
confirmed on urine specimens collected on a minimum of six
proteinuric rats. For subsequent experiments, in which semi-
quantification of amount of chemotactic factor production is
described, the 18 to 19 minute fraction from the HPLC purifi-
cation was utilized so as to exclude other more polar substances
which might be also present in urine or tubular supernatant.
Ethyl acetate extracts of urine of four protein-overloaded rats
at days 0, 1, 3, 7, and 14 were separated by HPLC and the
chemotactic activity eluting at 18 to 19 minutes was quantified
(Table 4). Chemotactic activity was present as early as day 1,
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)35
1-
(a
a)0
0
0
C.)
+0
-J
MAC 0X52 0X8 0X33
Control 9.5 2.1 0 0 0
Day 3 45.9 7.2a 0 0 0
Day 7 113.9 28.9" 1.7 0.8 6.5 1.la 0
Day 14 60.8 l0.7 5.9 0.4 14.2 o.7 2.9 0.39a
Interstitial cell infiltrate throughout the course of albumin overload.
Results expressed as l0 positive cells per gram of renal cortical tissue.
Antibody identification: MAC, recognizes macrophages; 0X52, recog-
nizes all T cells; 0X8, recognizes suppressor T cells; 0X33, recognizes
B cells. N = 3 for all time points tested for 0X8, 0X52 and 0X33, N =
3 to 6 for MAC.
a P 0.05 vs. control
ID 0.03 vs. control
Urine chemotactic activity
Fig. 4. Chemotactic activity in control unextracted urine, proteinuric
unextracted urine, and the aqueous and organic phases of the ethyl
acetate extract of proteinuric urine, expressed as number of cells
migrating in response to the chemoattractant. Proteinuric urine was
extracted at day 7. N = 3 for control and proteinuric unextracted urine,
N = 6 for proteinuric extracted urine.
50
45
40
Table 3 Interstitial cell enumeration
Peritubular
cells
ED-1(+)
cells
Control 197.3 3.3 18.3 4.8
Day 3 227.2 13.8 53.5 79
Day 7
Day 14
351.4 8.5"
366.4 6.2"
99.2 12.4a
199.3 27.7a
30
25
20
15
10
5
0
Control Day 3 Day 7 Day 14
Protein overload
Fig. 3. Cells positive for leukocyte common antigen (LC), expressed as
io positive cells per gram of cortical tissue. * P  0.03 vs. control. N
= 3 at each time point.
Table 2. Interstitial mononuclear cell infiltration in protein overload
Enumeration of renal cortical extratubular cells on light microscopic
sections, and of cells stained positively for ED-l on frozen section.
Values represent number of cells per 10 high power fields. N = 3 at all
time points.
a P  0.05 vs. controlb p  0.001 vs. control
50
40
000
30
0
00
and appeared to peak at day 3, concurrently with urine protein
excretion. However, differences between days 3 through 14 are
not statistically significant. Considerable chemotactic activity
was present in rat urine throughout the entire period of protein
overload.
Specificity of chemotactic factor
Following purification by HPLC as described, extracted
urine from rats at day 3 was tested for chemotactic activity
directed at monocytes, activated peritoneal macrophages, and
rat polymorphonuclear cells (Fig. 7). The substance was chemo-
tactic only for cells of the monocyte/macrophage line. No
neutrophil response was seen over the wide range of dilutions of
purified factor tested.
Modfication of urine chemotactic activity
The chemotactic lipid was subjected to alkaline and acid
hydrolysis, after extraction and passage over the preparative
silica columns. A total of 97% of chemotactic activity remained
in the extract following alkaline hydrolysis. However, after acid
hydrolysis, only 14% of activity was present. Heating the
extracted lipid to 100°C for one hour resulted in only slight
diminution of activity, to 83% of the original value. These
results were confirmed in urine samples collected from three
proteinunc rats.
*
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0
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A TLC of extracted proteinuric rat urine
CHCI5IMeOH/acetate; 60/25/5
B TLC of extracted tubular supernatants
R
CHCI3IMeOH/acetate; 60/25/5
Fig. 5. Representative thin layer chromatogram of chemotactic activ-
ity of extracted proteinuric urine (A) and extracted proximal tubule
culture (BSA -treated) supernatant (B). Results are expressed as number
of cells migrating toward the chemoattractant. The migration of authen-
tic standards is included for reference. Abbreviations are: PAF, platelet
activating factor; AA, arachidonic acid; OA, oleic acid; CO, cholesteryl
oleate; DL, dilinoleate; TL, trilinoleate.
Proximal tubule-associated chemotactic activity after albumin
exposure in vivo
Because the macrophage infiltrate localized around proximal
tubules, and because proximal tubules are exposed to high
albumin concentrations during proteinuric states, we investi-
gated whether proximal tubules could be a source of the
chemotactic lipid observed in the urine. Proximal tubules from
rats which had been protein-overloaded for seven days were
isolated as described and placed in overnight culture. More than
95% of the isolated tubules stained positively for alkaline
phosphatase, indicating that the preparation was essentially
pure for proximal tubules. Very few macrophages were seen
when the preparation was labeled with anti-macrophage anti-
body, again indicating an essentially pure culture.
Supernatants from these proximal tubular cultures were
harvested and lipids were extracted with ethyl acetate. The
extracted supernatant contained chemotactic activity (Table 5),
while extracted supernatant from culture of proximal tubules
from control rats was inactive. As was seen with the urine
derived activity, the active material from proximal tubular
supernatant also eluted between 18 and 19 minutes on HPLC.
Cultures which had been incubated with anti-macrophage anti-
serum and rabbit serum so as to lyse any contaminating
macrophages did not show a significant decrease in the produc-
tion of chemotactic activity when compared to cultures incu-
bated with fetal calf serum alone. This data makes it unlikely
that cells other than the proximal tubules, specifically adherent
macrophages, are responsible for production of the chemotactic
activity.
Subsequently, proximal tubules were isolated from rats after
0, 1, 3, 7 and 14 days of protein overload. The tubules were
placed into overnight culture and the following day, the super-
natants were harvested and extracted with ethyl acetate. The
organic phase of each extract was purified on HPLC as de-
scribed above. The chemotactic activity of the material eluting
between 18 and 19 minutes was measured. The results of these
assays are shown in Table 6. Chemotactic activity peaked after
the first day of protein overload, but remained present through-
out the entire time course of the experiment.
Proximal tubule-associated chemotactic activity after albumin
exposure in vitro
Proximal tubules from normal rats were placed in overnight
culture in K! medium containing 5 mg/mI of either lipid-replete,
or lipid-depleted BSA. Lipid-depleted BSA has been stripped of
the fatty acids usually carried by native, lipid-replete albumin.
The supernatant from the tubules cultured in the presence of
lipid-replete albumin contained chemotactic activity similar in
magnitude to that seen in the supernatants of tubules from the
protein overloaded animals (Table 5). However, the superna-
tants from the tubules cultured in the presence of lipid-depleted
albumin contained little activity. The activity from the super-
natants of the cultures exposed to lipid-replete BSA showed
mobility similar to the urine activity on TLC (Fig. Sb) and
HPLC (Fig. 6b). K! medium containing 5 mg/mi of either
lipid-replete or lipid-depleted BSA was also incubated over-
night in the absence of cells. The extract of this media showed
no chemotactic activity.
To ensure that the absence of chemotactic activity from the
proximal tubules cultured with lipid-depleted BSA was not due
to differences in proximal tubule cell uptake of lipid-replete
versus lipid-depleted BSA, cellular BSA content was measured
by ELISA as detailed under Methods. No significant difference
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7f(f Fig. 6. Representative HPLC chromatogramand chemotactic activity of extracted
6000 proteinuric urine (A) and proximal tubule
culture (BSA-treated) supernatant (B). UV
5000 absorption at 250 nm is shown as a solid line;
the numbers on the X-axis and above the
4000 peaks represent retention time. Chemotactic
activity of 1 minute fractions is shown on the
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the right hand axis. Control urine activity
2000 is shown as the dotted line. Results are
expressed as number of cells migrating toward
1000 the chemoattractant. The retention times
of authentic standards are included for0 reference. Abbreviations are: LPC,25 lysophosphatidylcholine; LTB4, leukotriene
B4; DAG, diacyiglycerol; FFA, free fatty
acid.
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Proximal tubule culture extract HPLC
in albumin content was seen between proximal tubules cultured
in lipid-replete or lipid-depleted BSA (23.2 6.1 ag albumin/mg
protein for lipid-replete vs. 28.3 9.8 g albumin/mg protein
for lipid-depleted). Approximately 75% ofuptake was blocked
by cold incubation, indicating that the majority of cellular
albumin uptake was specific. No albumin was detected in
control preparations which had not been exposed to BSA. LDH
release was measured in the some of the cultures as an indicator
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Table 4. Chemotactic activity of 18 minute HPLC fraction of
extracted urine
Chemotactic activity
% pos. control
Urine protein
mg/24 hr
DayO 5.0 2.8 5.9±0.3
Day 1 71.7 31.8 48.7 12.0
Day 3 137.0 38.1 603.0 185.9
Day 7 98.0 41.5 379.3 79.0
Day 14 111.0 15.0 261.3 5.6
Chemotactic activity of HPLC 18 minute fraction of proteinuric
urine, expressed as percentage of the activity of the positive control
response is shown. Urine protein values represent results only for those
rats included in this portion of the study. N = 4 rats. Urine was
collected on each day for each rat.
Cell specificity of lipid chemotactic factor
Fig. 7. Chemotaxis of several cell types in response to exposure to 18
minute fraction of HPLC purified proteinuric rat urine. Symbols are:
(0) rat polymorphonuclear cells; (•) RAW 264.7 monocyte cell line,
(A) rat pentoneal macrophages.
Control 1,068 365
Protein-overload (in vivo exposure) 15,782 2,146
Lipid-replete albumin (in vitro exposure) 13,142 2,129
Lipid-depleted albumin (in vitro exposure) 3,070 2,127
Chemotactic activity of proximal tubule segment cultures is shown.
Control consists of cultured tubules from normal rats; protein overload,
cultured tubules from protein overloaded rats at 7 days; lipid-replete
and lipid-depleted albumin, cultured tubules from normal rats, media
contained 5 mg/mI of the designated form of BSA. N = 3 experiments
for each group.
Table 6. Chemotactic activity of 18 minute HPLC fraction of
extracted tubular supernatant
Chemotactic activity
% pos. control
Urine protein
mg/24 hr
DayO 6.5 2.0 1.2 0.2
Day 1 64.5 15.5 57.8 8.8
Day 3 400 1.6 542.9 153.7
Day 7 25.3 3.9 227.4 56.0
Day 14 21.7 2.9 196.3 64.6
Chemotactic activity of HPLC 18 minute fraction of tubular super-
natant from protein overloaded rats is expressed as percentage of the
positive control response. Urine protein values represent results only
for those rats included in this portion of the study. N = 4 rats at each
time point.
proteinuric rats was found to contain a factor highly chemotac-
tic for monocytes. Both proteinuria and urine chemotactic
activity were maximal at three days of albumin loading, pre-
ceding the peak of the interstitial accumulation of monocytes.
The kinetics of chemotactic activity appearance are consistent
with the possibility that this proteinuria-associated chemotactic
factor may serve as the initiator of interstitial inflammation seen
in association with the nephrotic syndrome.
The localization of the infiltrating macrophages to the proxi-
mal tubules, and the knowledge that the proximal tubule is
Table 5. Chemotactic activity of tubular supernatants
Number of migrated cells
9
8
7
6
5
4
3
2
1
0
proteinuria results in amelioration of tubulointerstitial inflam-
mation and fibrosis [7, 9]. Previous studies have demonstrated
that dietary restriction of the essential fatty acids protects
against the interstitial infiltrate of experimental nephrosis [15],
0 1 50 1 20 11o 15 1 •2 1 as well as against the glomerular monocytic infiltrate seen in
acute glomerulonephritis [22], suggesting a link between lipid
Dilution metabolism and the susceptibility of the kidney to infiltration by
macrophages.
We have demonstrated a potential mechanism by which
significant proteinuna may be causally linked to interstitial
inflammation and subsequent fibrosis. The administration of
bovine serum albumin to rats, in sufficient quantities to induce
nephrotic-range albuminuria, induces interstitial inflammation
in the absence of detectable immune complexes, complement
activation, or other expressions of humoral immunity, as has
been previously described [101. The predominant infiltrating
leukocyte in the first phase of the interstitial inflammation is the
monocyte/macrophage; these cells clearly localize around prox-
imal tubules, in the absence of histologic evidence of tubular
toxicity. The monocytic infiltrate was seen as early as three
Discussion days after the initiation of albumin loading. The urine of the
of cell death. There was no difference in LDH release between
tubular segments not exposed to BSA, and those exposed to
either lipid-replete or lipid-depleted BSA. In all cases, LDH
release was low.
Clinical observations in human glomerulonephritidies have
suggested a link between the severity of glomerular proteinuria
and the evolution of nephrosclerosis [20]. Other studies have
implicated the presence of tubulointerstitial inflammation in
proteinuric states as predictive of both diminished glomerular
function and progression to end-stage renal disease in a wide
range of glomerulonephropathies including IgA nephropathy,
membranoproliferative glomerulonephritis, membranous ne-
phropathy, and cryoglobulinemia [3, 4, 6, 21]. In experimental
nephrosis in the rat, pharmacologic treatment which reduces
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exposed to high luminal albumin concentrations in proteinuric
states, led to investigation of whether proximal tubular cells
could be a source of the proteinuria-associated chemotactic
activity identified in the urine. Proximal tubules exposed to
albumin in vivo were found to release monocyte chemotactic
activity with identical chromatographic properties to the activ-
ity found in the urine. (Our observations do not preclude other
segments of the nephron as potentially contributing to the
interstitial infiltrate of proteinuna). Maximal chemotactic activ-
ity production in these experiments was seen after only one day
of protein overload, although significant activity was present
throughout the time period studied. This finding may represent
the difference in the timing of production of chemotactic factor
versus release into the urine.
Because the chemotactic factor is a lipid, we hypothesized
that it might be produced as the result of proximal tubular
metabolism of albumin-borne fatty acids. Unfortunately, it is
not possible to test this hypothesis in our in vivo model of
proteinuria. Free fatty acids bind to albumin with a tl/2 mea-
sured in milliseconds [23]. Therefore, delipidated albumin ad-
ministered intraperitoneally binds to fatty acids prior to the time
at which it reaches the urinary space. We did, however, explore
the hypothesis in the cell culture system. Cultured proximal
tubules exposed to lipid-replete BSA in the culture media
released a lipid macrophage chemotactic factor which was
chromatographically identical to the factor found in the urine.
This factor was not present in the supernatant of tubules
exposed to BSA which had been depleted of fatty acids. The
extract of media containing lipid-replete BSA which was not
exposed to proximal tubule cells had no chemotactic activity.
Thus, extracted fatty acids were not themselves chemotactic.
All of these data imply that, in states of heavy proteinuria,
proximal tubule cells, while processing large amounts of albu-
min and, more importantly, the associated fatty acids, produce
a lipid moiety which is highly chemotactic for macrophages.
Studies of the proximal tubular handling of albumin, partic-
ularly the comprehensive investigations of Maack and col-
leagues, have demonstrated that essentially all of the albumin
reabsorbed by proximal tubules is catabolized intracellularly to
its component amino acids. Proteinuria enhances the capacity
of the proximal tubule for albumin reabsorption and catabolism
[24]. However, there is no information on the metabolic fate of
fatty acids complexed to albumin. Albumin normally serves as
a carrier for free fatty acids, binding 3 to 30 molecules of fatty
acid per molecule of albumin [25]. Thus, it can be inferred that
the influx of albumin into proximal tubular cells which occurs
during proteinuria is coupled to an even greater uptake of fatty
acids. Weinberg and others have identified free fatty acids as
among the factors mediating cellular injury in models of tubular
ischemia [26]. It thus appears necessary that the tubular epithe-
hum convert albumin-borne free fatty acids into less toxic
forms. The monocyte chemoattractant which we have de-
scribed appears to be released as the result of the metabolism of
these fatty acids. Further studies of these metabolic pathways
are currently in progress.
Identification of the proximal tubular epithehial cell as a
potentially pro-inflammatory cell is consistent with other dem-
onstrations of the participation of proximal tubular epithelium
in interstitial immune reactions. Proximal tubular epithelial
cells may express MHC class II antigens in interstitial nephritis
[27] and human glomerulonephritis [28, 29], thus potentially
amplifying cell-mediated immune reactions in situ. Proximal
tubular cells can function as antigen-presenting cells to lympho-
cytes [30] and can secrete inflammatory cytokines such as
TNF [31], and an interleukin 1-like activity [32]. Renal cortical
epithelial cell production of IL-8, a potent chemoattractant for
neutrophils, has also been demonstrated [33].
The urine chemotactic factor of nephrosis has been identified
as a non-polar lipid based upon its extractability into ethyl
acetate, its lack of binding to silica, its migration on TLC, and
elution time in our reversed-phase HPLC system. Its chromato-
graphic properties appear identical to the chemotactic lipid
released by proximal tubule cells exposed to high concentra-
tions of albumin either in vivo or in vitro. It is highly significant
that proximal tubules exposed to dehipidated albumin did not
produce this chemotactic lipid. Thus the synthesis and release
of the factor appear dependent upon the metabolism of albumin-
borne fatty acids, and not upon the catabolism of albumin itself.
Various lipids have been shown to be immunologically active
in other studies of kidney disease. Administration of a platelet
activating factor (PAF) antagonist resulted in a partial amelio-
ration of interstitial nephritis associated with experimental
nephrosis produced by puromycin aminonucleoside administra-
tion [34]. Arachidonate metabolites have been implicated in the
pathogenesis of glomerular injury during nephrotoxic serum
nephritis [35, 36], while thromboxane A2 (TxA2) has been
associated with interstitial fibrosis and renal functional abnor-
malities following acute ureteral obstruction [14]. However,
each of these molecules is considerably more polar than our
activity with respect to silica binding, migration on TLC, and
elution profile with HPLC. Furthermore, proximal tubules
appear to possess neither endogenous cyclooxygenase nor
lipoxygenase activities; thus, proximal tubular eicosanoid pro-
duction is unlikely [37]. Although non-enzymatic oxidation of
arachidonate metabolites by proximal tubule cells has been
described, none of the products has been identified as associ-
ated with inflammation or as having comparable chromato-
graphic properties to our factor.
Identification of this chemotactic lipid requires purification to
homogeneity in sufficient quantities to allow mass spectros-
copy, and such purification is not yet complete. Enough is
currently known about its characteristics, nonetheless, to char-
acterize it as a previously undescribed, unique chemotactic
factor. Its migration on TLC and elution time on reversed-phase
HPLC identify it as a non-polar lipid. This distinguishes it from
other inflammatory lipids, such as PAF, the leukotrienes, and
TxA2, which have been implicated in glomerular and interstitial
inflammation. Previously identified lipid mediators of acute
inflammation such as PAF and leukotriene B4 are chemotactic
for neutrophils. The capacity of this lipid factor to selectively
recruit macrophages and the lack of neutrophil effect in vitro
(consistent with their absence in vivo in this model of protein-
uria) further characterize the factor we have described as a
novel lipid mediator.
The factor described here elutes approximately with diglyc-
erides. Based on the elution characteristics on silica columns,
migration on HPLC and TLC, and on the lack of staining with
molybdate, the factor shows no evidence of phosphorylation. In
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these systems we found that, in contrast to the lipid macro-
phage chemotactic factor, phosphorylated compounds were
retained on the silica column, were characteristically more
polar than the chemotactic factor (see standards, Figs. 5 and 6),
and were stained upon exposure of TLC plates to molybdate.
The factor's sensitivity to acid hydrolysis identifies the mol-
ecule as a complex neutral lipid. Many complex lipids are
formed by the estenfication of fatty acids to a glycerol back-
bone (for example, diglycerides and triglycerides). However,
ester bonds are sensitive to alkaline hydrolysis and resistant to
acid hydrolysis. The chemotactic factor was sensitive only to
acid hydrolysis, a characteristic suggestive of ether bonds. Our
current experiments have not precisely identified the structure
of the lipid chemotactic factor. However, ether bonds occur in
glycolipids and in sphingolipids, as well as in glycerol ethers.
Further purification and analysis are in process. Experiments
are also currently underway to explore the fate of internalized
fatty acids in models of nephrosis and to identify which of the
more than 20 fatty acids that may be complexed to albumin are
incorporated into the chemotactic factor by the proximal tubule
cell.
Based on these data, we propose a novel pathway linking the
interstitial inflammation and fibrosis associated with states of
unremitting, heavy proteinuria to tubular catabolism of filtered
albumin. We suggest that the intracellular release of free fatty
acids, liberated by the catabolism of their protein carrier,
results in the epithelial production and release of a novel lipid
chemotactic factor for macrophages that initiates the develop-
ment of reactive tubulointerstitial inflammation. The presence
of macrophages in a persistent, activated state could contribute
to interstitial fibrosis as a result of the numerous inflammatory
mediators released, including arachidonate metabolites, reac-
tive oxygen species, and peptide growth factors and cytokines
associated with stimulation of collagen synthesis and fibroblast
proliferation [38]. Additionally, the early arrival of the macro-
phage in the renal cortex in the context of proteinuria may
plausibly result in the subsequent recruitment of lymphocytes
and the initiation of events related to cellular immunity in situ.
The well-recognized association of leukocyte infiltration with
the subsequent development of interstitial fibrosis, and of
resultant changes in microvascular hemodynamics would pre-
dictably lead to the decrease in glomerular filtration and dimin-
ished tubular function which is the characteristic endpoint of
chronic, nephrotic-range proteinuria.
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